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Molecular Biology, University of Leeds, Leeds, UKABSTRACT Polybia-MP1 (MP1) is a bioactive host-defense peptide with known anticancer properties. Its activity is attributed
to excess serine (phosphatidylserine (PS)) on the outer leaflet of cancer cells. Recently, higher quantities of phosphatidyletha-
nolamine (PE) were also found at these cells’ surface. We investigate the interaction of MP1 with model membranes in the pres-
ence and absence of POPS (PS) and DOPE (PE) to understand the role of lipid composition in MP1’s anticancer characteristics.
Indeed we find that PS lipids significantly enhance the bound concentration of peptide on the membrane by a factor of 7–8. How-
ever, through a combination of membrane permeability assays and imaging techniques we find that PE significantly increases
the susceptibility of the membrane to disruption by these peptides and causes an order-of-magnitude increase in membrane
permeability by facilitating the formation of larger transmembrane pores. Significantly, atomic-force microscopy imaging reveals
differences in the pore formation mechanism with and without the presence of PE. Therefore, PS and PE lipids synergistically
combine to enhance membrane poration by MP1, implying that the combined enrichment of both these lipids in the outer leaflet
of cancer cells is highly significant for MP1’s anticancer action. These mechanistic insights could aid development of novel che-
motherapeutics that target pathological changes in the lipid composition of cancerous cells.INTRODUCTIONThe antimicrobial peptide Polybia-MP1 (IDWKKLLDAAK
QIL-NH2), or simply MP1, has unexpectedly been shown
to exhibit selective inhibition against several types of
cancerous cells and therefore could prove advantageous
in the development of novel chemotherapies. Extracted
from the Brazilian wasp Polybia paulista, MP1 has a broad
spectrum of bactericidal activities against Gram-negative
and Gram-positive bacteria without being hemolytic and
cytotoxic (1). Surprisingly, MP1 also selectively inhibits
proliferating bladder and prostate cancer cells (2), and
multidrug-resistant leukemic cells (3). Recently, it has
been observed that this peptide is cytotoxic against leukemic
T lymphocytes and very selective in recognizing these cells
compared to healthy lymphocytes (4).
Cancer cell membranes are now known to lose the asym-
metric transmembrane distribution of phospholipids that is
observed in healthy cells (5,6). In healthy mammalian cells,
the anionic aminophospholipid PS (phosphatidylserine) is
predominant in the inner membrane leaflet and zwitterionic
phospholipids are predominant in outer membrane leaflet. InSubmitted January 30, 2015, and accepted for publication July 22, 2015.
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0006-3495/15/09/0936/12such cells, the phospholipid asymmetry is maintained by a
family of aminophospholipid translocases that catalyze the
transport of PS from the outer to the inner membrane leaflets
(7). However, in apoptotic and cancer cells, PS is found to
also be located in the outer monolayer of the plasma mem-
brane in significant proportions (5,6).
The molecular-scale mechanistic basis for MP1’s anti-
cancer properties is yet to be established. Changes in the dis-
tribution and/or composition of lipids (e.g., PS) within the
plasma membrane of malignant cells could be the origin
of MP1’s cancer selectivity. This is a reasonable hypothesis,
based upon the well-established selectivity of antimicrobial
peptides for bacterial membranes over eukaryotic mem-
branes due to their higher anionic lipid content (8–11).
Recently, the effect of PS on the pore-forming activity of
MP1 was investigated by multiple techniques, namely,
conductance measurements in planar bilayer lipid mem-
branes, binding assays, and lytic activity on large unilamel-
lar vesicles (4). Although an increase in affinity and lytic
activity of MP1 for lipid vesicles containing PS was
observed, MP1’s pore-formation activity in BLM showed
no difference between PC (phosphatidylcholine) and mixed
PC/PS bilayers. Significantly, it was recently reported that
PE (phosphatidylethanolamine) lipids, naturally found on
the inner plasma membrane of normal cells, are also exter-
nalized to the outer monolayer of the plasma membrane ofhttp://dx.doi.org/10.1016/j.bpj.2015.07.033
Membrane Poration by Anticancer Peptide 937apoptotic and tumor endothelial cells due to both PS and PE
lipids being coregulated by the same transporters (7). These
authors observed that the exposure to the outer monolayer of
one of these phospholipids leads to the exposure of the
other. Therefore, it is important for future work to establish
the role of increased concentrations of both PE and PS lipids
in the interaction of MP1 with membranes.
In this work, we address this challenge by establishing
the roles of PE and PS lipids in the effects of MP1 on the
structure and permeability of model membranes. Primarily,
we study the permeability of giant unilamellar vesicles
(GUVs) at the single vesicle level. Fluorescence confocal
microscopy was used to determine the size-dependent
macromolecular permeability of lipid membranes in GUV
model systems by analyzing the influx of three fluorescent
dyes with molecular masses of 0.37, 3.0, and 10.0 kDa
into these vesicles (Fig. 1). We deconvolve the effects of
PS and PE lipids by exploring their effects within DOPC
(PC) membranes both separately and in combination:
DOPC/POPS 80:20 (PC/PS), DOPC/DOPE 90:10 (PC/
PE), and DOPC/DOPE/POPS 70:10:20 (PC/PE/PS). These
experiments are corroborated by circular dichroism (CD)
spectroscopy to quantify peptide binding to the membrane,
fluorescence spectroscopy experiments to establish the
leakage mechanism in an ensemble system of nanoscale
large unilamellar vesicles (LUVs), and atomic-force micro-
scopy (AFM) imaging of supported lipid bilayers to reveal
the nanoscale perturbations of membrane structure induced
by the peptide. By combining these approaches, we show
that, while PS lipids significantly enhance MP1’s binding
onto the membrane, PE lipids impart the most significantcontribution to the rate and extent of membrane permeabili-
zation by MP1, facilitating the opening of larger membrane
defects than in bilayers lacking in PE.MATERIALS AND METHODS
Materials
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DOPE (1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine), POPS (1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phosphoserine), and Rh-DOPE (1,2-dioleoyl-sn-glycero-3-phosphoe-
thanolamine-n-(lissamine rhodamine B sulfonyl) (ammonium salt) were
purchased from Avanti Polar Lipids (Alabaster, AL). A quantity of
10 kDa Alexa Fluor 647-labeled dextran (10k-AF647), 3 kDa Cascade
Blue-labeled dextran (3k-CB), ANTS (8-aminonaphtalene-1, 3, 6-trisul-
fonic acid sodium salt), and DPX (p-xylenebis (pyridinum) bromide)
were purchased from Invitrogen Molecular Probes (Waltham, MA). CF
(carboxyfluorescein) (370 MW) and all other reagents were purchased
from Sigma-Aldrich (St. Louis, MO). Buffer: 10 mM HEPES and
150 mM NaCl, pH 7.4.Peptide synthesis and purification
MP1 (Polybia-MP1) was synthesized, as described in de Souza et al. (1,12)
by stepwise manual solid-phase synthesis using Fmoc (N-9-fluorophenyl-
methoxycarbonyl) chemistry. The crude product was purified by reverse-
phase HPLC and the homogeneity and sequence was assessed by analytical
HPLC and electrospray ionization (ESI) mass spectrometry.Mass spectrometry analysis
The homogeneity of peptide preparationswere ascertained bymass spectrom-
etry. Samples were analyzed on a triple quadrupole mass spectrometer, model
QUATTRO II, equipped with a standard ESI probe (Waters/Micromass,FIGURE 1 Schematic representation of mem-
brane disruption by peptides and the experimental
system. The helical peptide Polybia-MP1 is shown
according to the helical wheel projections. Amino
acids: (blue) polar with positive net charge; (pur-
ple) polar with negative net charge; (red) polar
noncharged; and (green) nonpolar. Confocal micro-
scopy was performed to investigate the influx of
three dyes with distinct sizes in GUVs in the
presence and absence of PE lipids: 0.37 kDa CF
(green), 3k-CB (blue), 10k-AF647 (magenta),
and the scale bars correspond to 10 mm. Lipid
membranes are labeled with Rh-DOPE (red). The
peptide interacts with the GUVs, disturbs their
structure, and then enables the passage of fluores-
cent dyes by formation of pore-like structures. To
see this figure in color, go online.
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temperaturewasmaintained at 80Cand the needlevoltage at 3.6 kV, applying
a drying gas flow (nitrogen) of 200 L/h and a nebulizer gas flow of 20 L/h. The
mass spectrometer was calibrated with intact horse heart myoglobin and its
typical cone-voltage-induced fragments. The molecular masses were deter-
mined by ESI mass spectrometry by adjusting the mass spectrometer to give
a fullwidth at half-maximumof1mass unit. Thevoltage between cone sample
and skimmer lens that controlled the ion transfer to the mass analyzer was set
to 38 V. Approximately 50 pmol (10 mL) of each samplewas injected into the
electrospray transport solvent. The ESI spectra were obtained in the multi-
channel acquisition mode; the mass spectrometer data acquisition and treat-
ment system was equipped with MASSLYNX and TRANSFORM software
(Waters) for handling spectra.GUV formation
GUVs composed, respectively, of 100% DOPC (PC); 80% DOPC and 20%
POPS (PC/PS); 90% DOPC and 10% DOPE (PC/PE); and 70% DOPC,
10% DOPE, and 20% POPS (PC/PE/PS) were formed by the electroforma-
tion method as follows. Chloroform stock solutions of the lipid mixture and
the fluorescent lipid Rh-DOPE (0.5 mol %) were prepared at a total lipid
concentration of 1.0 mM. A quantity of 50 mK of lipid solution was added
dropwise onto the platinum wires of the electroformation chamber and
dried under vacuum from 2 to 4 h. The chamber was then filled with a
300-mM sucrose solution and the peak-to-peak voltages of 6.5 Valternating
current, for zwitterionic lipid mixtures, or 4.5 V alternating current, for
anionic lipid mixtures, was applied across the platinum wires at distinct fre-
quencies: 10 Hz for 30 min, 3.0 Hz for 15 min, 1.0 Hz for 7 min, and 0.5 Hz
for 7 min. The GUVs were prepared at room temperature. Once formed,
GUV solutions were harvested from the electroformation chamber and
stored in foil-wrapped plastic vials before imaging.LUV preparation
LUVs composed of the same lipid mixtures as the GUVs were prepared ac-
cording to general procedures with slight modifications, as outlined below.
Briefly, phospholipids dissolved in chloroform were dried under N2 flow in
a round bottom flask. The lipid film was completely dried under vacuum for
at least 3 h and afterwards hydrated either with 10 mM phosphate buffer
containing 150 mM NaF for binding experiments, or with ANTS 5 mM
and DPX 8 mM both prepared in HEPES buffer for the requenching assay.
In both preparations the final lipid concentration was ~10 mM. The suspen-
sion was submitted to two extrusion steps using an Avanti Mini-Extruder
(Avanti Polar Lipids) and double-stacked polycarbonate membrane (Nucle-
opore Track-etch Membrane; Whatman, Florham Park, NJ): first, 6 times
through 0.4 mm and then 11 times through 0.1 mmmembranes. The dye-en-
trapped LUVs were separated from unencapsulated fluorophores by gel
filtration on a Sephadex G25M column (Amersham Pharmacia Biotech,
Piscataway, NJ). Vesicles were used within 48 h of preparation. The lipid
concentrations were determined by phosphorus analysis (13).CD spectroscopy for binding isotherms
A solution of 10 mM MP1 in buffer was titrated with increasing lipid con-
centrations of zwitterionic (PC and PC/PE) or anionic (PC/PS and PC/PE/
PS) LUVs up to 1.5 mM. The highest lipid concentration used was>10/Kp,
where Kp is the partitioning coefficient, which assures that all the peptides
are bound in anionic and zwitterionic vesicles (14). After each lipid addi-
tion the CD spectra were collected from 260 to 190 nm, at 25C, with
a Jasco-815 spectropolarimeter (JASCO International, Tokyo, Japan),
which was routinely calibrated at 290.5 nm using d-10-camphorsulfonic
acid solution and a 0.2 cm path-length cell. The spectra were averaged
over 15–30 scans, at a scan speed of 50 nm/min, bandwidth of 1.0 nm,Biophysical Journal 109(5) 936–9471.0 s response, and 0.2 nm resolution. After baseline correction, the
observed ellipticity at 222 nm, q (mdeg), was converted to mean residue
ellipticity [Q] (deg cm2/dmol), using the relationship [Q] ¼ 100q/(l c N),
where l is the path length in cm, c is the peptide concentration in mM,
and N is the number of peptide residues.
The plots of the normalized molar ellipticity (Qobs /Q0) as a function of
the lipid concentration were fitted with the equation
Qobs
Q0
¼ 1þ

QH
Q0
 1

Kp½L
1þ Kp½L

;
where Q0 is the molar ellipticity per residue at 222 nm in the absence of
LUVs, [L] is the total lipid concentration, and Q /Q is the maximum-H 0
normalized molar ellipticity.Confocal microscopy
Vesicle samples were imaged at room temperature by using a model No.
LSM 510 META (Zeiss, Jena, Germany) inverted confocal microscope.
The objective lens used was a 63/1.4 N.A. Oil Plan-Apochromat. The
Rhodamine probe was excited by a DPSS laser at 543 nm, the CF probe
was excited with the 488 nm line of an Argon laser, the Cascade Blue
was excited at 405 nm with a diode laser and the Alexa Fluor 647 was
excited with the 633-nm line of a Helium Neon laser. Small plastic Petri
dishes with glass coverslips on the bottom (Cat. No. P35G-1.5-14-C;
MatTek, Ashland, MA) were used as observation chambers. The glass
was treated with a 10% bovine serum albumin solution (10 min) and then
washed with deionized water to avoid vesicle adhesion to the glass (15).
A quantity of 20 mL of GUV solution and 75 mL of buffer were incubated
for 15 min before imaging to allow the GUVs to sediment to the bottom of
the sample. This is due to the higher density of the sucrose solution inside
the GUVs in contrast to the surrounding buffered saline solution.
CF, 3k-CB, and 10k-AF647 were diluted in HEPES buffer to obtain so-
lutions with final concentration of between of 3–30 mM and were pipetted
carefully to the top of the sample. Images and movies of the vesicles in
the mixture with buffer and the three dyes were recorded as a control ex-
periment. For the quantitative analysis of the dye influx process, the con-
centration of dye in the interior of the vesicles was normalized on a
scale of 0–1 according to the equation c(t) ¼ (binterior, t – binterior, control)/
(bexterior – binterior, control). The value bexterior is the average pixel intensity
in a region of the bulk solution, binterior, t is the average pixel intensity of
dyes in the interior of GUVs after t seconds after peptide addition, and bin
terior, control is the average pixel intensity of the dyes in the interior of GUVs
in the unleaked control samples (i.e., the background signal). This proce-
dure allowed us to monitor leakage events of individual GUVs for a period
of up to 30 min after peptide addition and to quantify the permeability of
GUVs during leakage events.Analysis of confocal images and movies
Confocal images and movies were analyzed using IMAGEJ software (Na-
tional Institutes of Health, Bethesda, MD). As a criterion, aggregated and
multilamellar vesicles and vesicles with a diameter <8 mm were excluded
from the analysis. Images of GUVs were obtained after 30 min of MP1
addition at total final concentrations 4 or 40 nM, and 0.4, 1.2, or 4.0 mM.
This was done to investigate the influx percentage of different-sized dyes
as a function of peptide concentration (Cp). The percentage of dye influx
was obtained by rescaling dye influx fraction c in terms of a percentage.
In the movies, single vesicles were monitored over time immediately after
peptide addition, at a fixed Cp ¼ 4.0 mM, for a period of up to 30 min or
until GUVs had fully leaked. For vesicles that moved during the course
of the movie, the region of interest was changed to keep it within the vesicle
interior. The average background intensity was also monitored over time by
selecting an external region near the observed vesicle. Vesicle permeability
Membrane Poration by Anticancer Peptide 939(Pm) was calculated as the gradient of the log-linear plot of the time-depen-
dent influx, –R/3 ln (1 – c(t)) against time t (16,17). R is the observed vesicle
radius and c(t) is the dye influx fraction.ANTS/DPX requenching measurements
LUVs with entrapped 5 mM ANTS and 8 mM DPX in HEPES buffer, pH
7.4, were prepared and submitted to MP1 interaction to establish the mech-
anism of leakage for the four studied lipid compositions. It is possible by
determining the dependence of the quenching of ANTS, with the quencher
DPX, inside the vesicles (Qin) as a function of the ANTS fraction outside
the vesicles (fout), to differentiate between all-or-none and gradual leakage
mechanisms, as proposed by Ladokhin et al. (18). If Qin remains constant
and at ~0.2 as fout increases, then the peptide exhibits an all-or-none mech-
anism of leakage. If Qin increases with fout, then it suggests the gradual
mechanism of leakage. The ANTS fluorescence intensity was collected
with a PC1 spectrofluorometer (ISS, Champaign, IL) with excitation at
355 nm and emission at 520 nm. Excitation and emission bandwidth
were set at 1.0 and 2.0 nm, respectively. DPX 25 mM was titrated into sam-
ples containing 100 mM of lipid and increasing peptide concentrations
ranging from 0 to 40 mM. Each peptide sample was kept 2 h to equilibrate
until the fluorescence signal stabilized, to ensure that MP1 activity was
complete. At the end, to obtain the fluorescence signal corresponding to
the complete leakage, 25 mL of 10% Triton X-100 was added to each sam-
ple. The fluorescence signals were converted to Qin and fout and plotted to
obtain the mechanism of leakage curve.AFM
Lipids and cholesterol were purchased in dry form from Avanti Polar Lipids
and solvated to 5 mM in chloroform. Supported bilayers were formed from
these lipids by the vesicle fusion method. Specifically, solvated lipids were
mixed in a glass vial to the correct molar proportion, dried under a gentle
stream of N2, and then placed under vacuum overnight to ensure no chloro-
form remained. The mixture was then hydrated using the buffer solution to a
lipid concentration of ~0.5 mg/mL. The suspension was then tip-sonicated
until the solution clarified, indicating formation of small unilamellar vesi-
cles. The buffer solution used throughout bilayer preparation and imaging
was 125 mM NaCl and 10 mM HEPES at pH 7.4.
A quantity of 100 mL of the lipid vesicle solution was pipetted onto a
freshly cleaved mica substrate along with 50 mL of a solution of 10 mM
MgCl2 to aid vesicle fusion and create a perfect defect-free supported
bilayer. The sample was then incubated in a humid environment at 50C
for ~1 h, allowing the vesicles to sediment and rupture on the surface to
form a continuous bilayer. The bilayer was then rigorously rinsed 10 times
with 100 mL warm (50C) buffer using a pipette (Gilson, Madison, WI), the
wash directed parallel to the bilayer surface to remove adhering vesicles.
AFM experiments were carried out using a Multimode 8 AFM on a
Nanoscope V controller (Bruker, Billerica, MA), and equipped with a fluid
cell. Bruker NP-A probes (kz 0.35 Nm1) were operated in contact mode.
Although tapping mode in fluid often produces sharper images, it was found
that the erosion of the bilayer by the antimicrobial peptide caused debris
from the bilayer to float freely in solution, compromising the interactions
between tip and sample. Contact mode is generally less susceptible to these
effects and thus was more suited. It is also faster than peak-force tapping
mode, important when attempting to capture dynamics. After acquisition
of several images of the clean bilayer without peptide, the antimicrobial
peptide was added manually to the bilayer using a pipette (Gilson). A quan-
tity of 150 mM peptide in buffer was added such that the final peptide con-
centration within the cell was 4 or 10 mM. The MP1 concentration was
chosen such that statistically significant membrane perturbations could be
observed within the comparatively small imaging area of the AFM within
an experimentally accessible timescale. Many different regions of each
bilayer were imaged to ensure a representative view of the sample wasobtained, unless time-resolved experiments were taking place, when the
imaging region was fixed for the whole of one experiment to see the direct
effect of peptide injection. Maximum scan size was equal to 13 mm. Each
preparation of peptide on each lipid mixture was carried out at least three
times, and usually five times, to assure reproducibility. Temperature was
not controlled, but would stabilize between 25.5 and 26.0C within
20 min of injection.Phase contrast microscopy
GUVs were observed by phase contrast microscopy, in which the differ-
ences in density and refractive index between sucrose inside the vesicles
and buffer outside the vesicles provide better contrast for observation under
the microscope (model No. IX71, equipped with charge-coupled device
cameras; Olympus, Melville, NY). Small plastic Petri dishes with glass
coverslips on the bottom (Cat. No. P35G-1.5-14-C; MatTek) were used
as observation chambers after a treatment with a 10% bovine serum albu-
min solution (10 min) (15). A quantity of 20 mL of GUV solution and 75
mL of buffer were incubated for 15 min before imaging to allow the
GUVs to sediment to the bottom of the sample. After this, MP1 solution
prepared in HEPES buffer was added to the observation chamber with a
final concentration of 4 or 10 mM. The vesicles were observed under a
40 phase contrast objective for 2 h. The sizes of the GUVs before and dur-
ing peptide interaction were obtained by measuring the average vesicle
diameter for a period of 5 min at t z 0, 30, 60, 90, and 120 min.RESULTS
PS lipids significantly enhance peptide binding to
the membrane
The overall efficacy of a peptide at disrupting a target mem-
brane can be broken down into the combination of two
sequential steps: 1) binding of the peptide to the membrane
surface, and 2) the efficiency of membrane disruption by the
bound peptide resulting in membrane poration or leakage.
First, we investigate the membrane binding isotherms of
the MP1 peptide to our four lipid compositions of interest
by CD spectroscopy by titrating a 10 mM MP1 solution
with increasing lipid (LUV) concentrations (Fig. 2). Fitting
these binding isotherms revealed that the partition coeffi-
cient (Kp) of the peptide was 7–8 times higher for membrane
compositions containing PS (Kp values were PC 4600 M
1,
PC/PE 4000 M1, PC/PS 33,000 M1, and PC/PE/PS
30,000 M1). It is also interesting to note from this data
that PE lipids slightly suppress peptide binding by a factor
of ~10%. Due to the cationic nature of MP1 (net charge
ofþ2e), it is highly likely that the enhanced peptide binding
to anionic-PS-containing membranes is primarily driven by
electrostatic interactions.MP1 dose-response studies reveal that PE and PS
lipids enhance membrane permeability at lower
peptide concentrations
To investigate the efficiency of membrane disruption, we
measured the leakage of macromolecules across GUV
model membranes by confocal fluorescence microscopy.
Fluorescent passive leakage markers of different sizesBiophysical Journal 109(5) 936–947
FIGURE 2 Binding isoterms show that MP1 has a higher affinity for PS-
containing membranes. The binding isoterms and the partition coefficients
(Kp) obtained using CD by lipid titration at 10 mMMP1 solution. LUVs are
composed of (a) PC, (b) PC/PE, (c) PC/PS, and (d) PC/PE/PS.
FIGURE 3 Dose-response curves show increased leakage of PE con-
taining GUVs at lower peptide concentrations. (a and c) Percentage of
GUVs filled by CF (0.37 kDa) after 30 min incubation time with MP1. (b
and d) Percentage of GUVs filled by 10k-AF647 after 30 min incubation
time with MP1. All vesicles presenting >20% of dye entry were accounted
as filled. The data is plotted as a function of (a and b) total peptide concen-
tration and (c and d) the concentration of peptide bound to the membranes.
Fifty GUVs were used to construct each data point. Vesicles are composed
of PC, PC/PS, PC/PE, and PC/PE/PS. To see this figure in color, go online.
940 Leite et al.were simultaneously employed: 0.37 kDa carboxyfluores-
cein (CF), 3 kDa dextran labeled with Cascade Blue (3k-
CB), and 10 kDa dextran labeled with Alexa Fluor 647
(10k-AF647). GUVs were composed of PC, PC/PS, PC/
PE, or PC/PE/PS. The dose-response of the membranes to
the addition of MP1 was characterized for each membrane
composition and passive leakage marker by evaluating the
normalized fluorescence intensities of the probes in the in-
travesicular lumen of the GUVs after 30 min incubation
time (Fig. 3 and Fig. S1 in the Supporting Material). Each
data point in Figs. 3 and S1 shows the mean leakage of 50
individual GUVs from a minimum of two independent ex-
periments. For determining the percentage of leaked vesi-
cles (Fig. 3), a threshold of 20% leakage (normalized to
the background probe concentration) was used to define a
filled vesicle. Alternatively, this data can be analyzed in
terms of the average leakage into GUVs as a percentage
of the probe concentration in the external medium (Fig. S1).
The integrity of membranes containing both PE and PS
lipids is perturbed by lower concentrations of MP1 peptide
than the other membrane compositions we investigated. PC/
PE/PS GUVs show significant (40–65%) leakage to the CF
probe at 0.4 and 1.2 mMMP1 concentrations, whereas other
membrane compositions studied leaked <30% within this
concentration range (Fig. S1 a).
Larger pore defects, evidenced by leakage of the larger
10k-AF647 probe, are shown to be significantly enhanced
in membranes containing 10% PE. Almost all GUVs
(98%) containing PE lipids are observed to leak the 10k-
AF647 probe when in the presence of 4.0 mM MP1,
compared to <60% of GUVs for other membrane composi-
tions at the same peptide concentration (Fig. 3 b). This is the
most significant enhancement in selective perturbation forBiophysical Journal 109(5) 936–947specific lipid membrane compositions observed within the
dose-response data in Figs. 3 and S1. At this MP1 concen-
tration, membranes under native conditions would be sus-
ceptible to the leakage of biological macromolecules such
as small proteins and RNAs.
Interestingly, we also plot the GUV leakage data as a
function of the concentration of bound peptide on the mem-
brane using the specific partition coefficients of the peptide
for different lipid compositions that were calculated in
Fig. 2 (see also Figs. 3, c and d, and S1, c and d). This rep-
resentation of the data clearly shows that PE lipids increase
the susceptibility of PC membranes to disruption by the
MP1 peptide, with PC/PE lipids leaking at significantly
lower bound peptide concentrations. Due to the higher
bound concentration of peptide to membranes containing
PS lipids, this lipid decreases the apparent susceptibility
of the membrane to leakage as observed by the onset of
leakage shifting to higher bound peptide concentrations.
For PC/PE/PS GUVs, the apparent competing effects of
PE and PS lipids on the membrane’s leakage susceptibility
roughly cancel each other out, leading to intermediate mem-
brane disruption susceptibility for a given bound peptide
concentration. However, the effect of increased bound pep-
tide concentrations due to PS far outweighs its apparent in-
hibition of membrane leakage, making PC/PE/PS GUVs the
most susceptible to leakage for a given total peptide concen-
tration. Therefore, the combined roles of PS in increasing
Membrane Poration by Anticancer Peptide 941membrane binding and PE in increasing the susceptibility of
the membrane are both important in increasing the mem-
brane disruptive efficacy of MP1.FIGURE 4 Fluorescence requenching assays for MP1 reveal all-or-none
leakage in the four lipid compositions studied. Qin is constant as a function
of fout for MP1, which is in agreement with the all-or-none mechanism of
dye release.) (Lines) Theoretical curves for ideal graded and all-or-none
dye release (18). To see this figure in color, go online.Confirmation of the pore-formation hypothesis in
lipid vesicles
Fluorescence spectroscopy experiments using LUVs give
ensemble-averaged measurements with high statistics on a
large population of vesicles, complementing single-vesicle
GUV imaging experiments that inherently have lower statis-
tics but yield information on the distribution of behaviors
and rare events within a sample. The fluorescence requench-
ing method (18) enables us to distinguish the type of leakage
mechanism induced by MP1 for the lipid compositions
under investigation. One possibility is the all-or-none mech-
anism where some vesicles release all of their internal con-
tents while the others remain intact. This is attributed to
pore-formation mechanisms of membrane perturbation, or
complete vesicle lysis. Another possibility is the gradual
leakage mechanism where vesicles only release a fraction
of their encapsulated contents during a leakage event. This
is associated with transient perturbations of the membrane.
A fluorophore (ANTS) and a quencher (DPX) are encapsu-
lated within lipid vesicles at high concentrations such that
the fluorescence is initially quenched; vesicle leakage re-
sults in the release of both ANTS and DPX, but quenching
is decreased due to dilution of these probes. The external-
ized ANTS fluorescence can be suppressed by additional
titration of DPX such that the remaining fluorescence signal
is only due to the ANTS inside intact vesicles. The data can
be represented by a plot of the degree of quenching (Qin)
against the released ANTS fraction (fout). In the case of an
all-or-none leakage mechanism, the plot of Qin versus fout
will show no dependence of Qin on fout. In contrast, the
gradual leakage mechanism causes release of only a fraction
of the encapsulated contents within individual vesicles and
so Qin increases with increasing fout (18).
Fig. 4 shows that the values ofQin remain constant with the
increase of fout and the consequent increase of peptide/lipid
molar ratios. This clearly shows that MP1 exhibits the all-
or-none leakage mechanism for all lipid compositions
studied, which is in contrast to what has been observed for
antimicrobial peptides mastoparan X and mastoparan MP
(19). We propose that this all-or-none leakage is related to
peptide-induced pore formation (20–23), where the vesicles
are able to release all their internal contents through pore-
like structures that are sufficiently long lived (23–28). We
do not solely attribute the all-or-none leakage to lysis of the
vesicles because nonlysed, leaky vesicles are observed in
our GUVexperiments (Figs. 3 and S1). However, we do not
discount the possibility that lysis might play a role in the
LUV leakage at the highest peptide concentrations used in
this assay. Furthermore, pore-like activity of MP1 has previ-
ously been identified from electrophysiology measurementsin planar lipid bilayers composed of phytanoyl-PC and phy-
tanoyl-PC/PS (70:30) (4).
Our fluorescence requenching results show that stable
pores form with a lifetime that persists long enough for
the dye efflux to reach equilibrium in LUV systems. How-
ever, this does not discount the possibility that pores might
be transient over longer timescales, for example during the
leakage of much larger vesicles such as GUVs where the
encapsulated volume of dye that needs to be released during
a leakage event is ~106 times greater than for the LUV
model system. Indeed, we will see some evidence for tran-
sient pore events and dynamic changes in membrane per-
meability in the single GUV leakage kinetics data that
follows. Nevertheless, all-or-none leakage is clearly evident
in GUVs after 30 min incubation with 1.2 and 4.0 mMMP1.
Leakage histograms of the individual GUVs (an alternative
representation of data shown in Figs. 3 and S1) predomi-
nantly show either <e20% (unleaked) or >e80% (fully leaked)leakage (Fig. S2).
Synergistic enhancement of GUV leakage kinetics
by PE and PS lipids
Analysis of the time delay from the start of our GUVexper-
iments (addition of the peptide) to observations of the onset
of GUV leakage reveals a synergistic reduction in this lag
time for PC/PE/PS membranes (Table 1 and Fig. 5). In these
GUV experiments, we add 4.0 mM MP1 to our samples and
monitor the time taken for initial leakage events of GUVs to
the 0.37 kDa CF probe to occur (t0  tCF). This MP1 con-
centration is chosen as it causes significant leakage of
GUVs within 30 min of peptide addition across all four
lipid compositions of interest. The onset of leakage occurs
approximately twice as quickly for PC/PE/PS GUVs than
for other membrane compositions, with only a very slight
reduction of the lag time for PC/PS membranes comparedBiophysical Journal 109(5) 936–947
TABLE 1 Lag times between the onset of leakage of each dye
and the time interval before the initial leakage takes place after
the addition of peptide
Time Delays (s) PC/PE PC/PE/PS PC/PS PC
t0  tCF 16005 110 7605 120 14005 60 1600
tCF – t3k-CB 1.8 5 0.6 1.55 0.3 41 5 5
a 1605 110
tCF – t10k-AF647 4.2 5 1.5 2.05 0.4 525 6 2205 66
t3k-CB – t10k-AF647 2.7 5 0.9 1.45 0.4 9.65 1.2 605 42
The errors represent the standard deviation of the observed GUV data set.
aFor PC/PS GUVs, the tCF – t3k-CB data only includes GUVs that leaked to
all three dyes; these sample conditions contained two distinct populations
of GUV leakage behaviors where a second population of GUVs only leaked
to the CF and 3k-CB dyes with a time delay of tCF – t3k-CB ¼ 4.85 0.6 s.
FIGURE 5 GUV permeabilization kinetics are synergistically enhanced
by PE and PS lipids. (a) Comparison between dye influx kinetics of three
distinct dyes (CF-0.37kDa, 3k-CB, and 10k-AF647) for PC/PE/PS and
PC/PS GUVs. The time axis represents the time after peptide addition.
These individual GUV leakage profiles were chosen as they represent the
average behavior of the GUVs observed under these conditions. (b) Sche-
matic representation of the dye influx kinetics for PC/PS and PC/PE/PS
GUVs in the presence of CF and 10k-AF647 passive leakage markers.
942 Leite et al.with PC/PE and PC GUVs. Therefore, this is not a purely
electrostatic effect from the increased rate and extent of
peptide binding to anionic PS-containing membranes; it
also requires the presence of PE to significantly increase
the susceptibility of the membrane to permeabilization.
We also quantify the average delay times between leakage
of the different-sized fluorescent probes between CF and
3k-CB (tCF – t3k-CB), CF and 10k-AF647 (tCF – t10k-AF647),
and 3k-CB and 10k-AF647 (t3k-CB – t10k-AF647). Once the
initial leakage event occurs, PE-containing GUVs rapidly
become leaky to fluorescent probes of larger sizes (3 and
10 kDa). For PC/PE/PS and PC/PE membranes, GUVs
become leaky to larger 3k-CB, then 10k-AF647 passive
leakage markers within seconds of permeabilization to the
smallest CF (0.37 kDa) probe (Table 1). The consecutive
delay times between CF and 3k-CB probes and 3k-CB and
10k-AF647 probes were approximately an order-of-magni-
tude longer for PC/PS membranes, and almost two orders-
of-magnitude longer for purely PCmembranes. This strongly
implies that the presence of PE significantly enhances the
favorability and rate of formation of largermembrane defects
or pores.This shows the average lag times for GUV leakage after the addition of
4.0 mM MP1 and the typical average leakage extent of the GUVs that re-
sulted in these experiments. To see this figure in color, go online.
PE lipids significantly enhance pore size and
membrane permeability
We use time-series confocal microscopy imaging to quan-
tify the membrane permeability of GUVs during initial
leakage. Quantification of the fluorescence intensity of the
leakage markers in the intravesicular and extravesicular
medium allows us to calculate the fractional leakage of
individual GUVs as a function of time. The leakage kinetics
of individual GUVs are monitored for up to 30 min after the
addition of 4.0 mM MP1. This concentration is chosen as
all lipid compositions show significant leakage within
30 min; a higher MP1 concentration of 10 mM is observed
to induce significant lysis of GUV samples (Fig. S3).
These experiments are conducted on GUVs of all four
membrane compositions under investigation, using the CF,
3k-CB, and 10k-AF647 leakage markers simultaneously.
This allows the time evolution of membrane permeabilityBiophysical Journal 109(5) 936–947to different molecular sizes to be simultaneously measured
for individual GUVs (Figs. 5 a and S4). To the best of our
knowledge, this is the first example of simultaneous size-
dependent permeability measurements in GUVs for three
different-sized leakage markers.
Typical leakage kinetic profiles for different membrane
compositions and probe sizes are shown in Figs. S4 and 5
a. It can be qualitatively seen from these example profiles
that membrane compositions containing 10% PE exhibit
full and rapid membrane leakage for all three sizes of
leakage marker, consistent with the leakage kinetics
data in Table 1, which is also outlined in Fig. 5 b. For mem-
brane compositions lacking PE, the leakage rates can some-
times be seen to increase and decrease intermittently,
sometime plateauing before full leakage is achieved; this
Membrane Poration by Anticancer Peptide 943is particularly evident in the leakage profile of a single PC/
PS GUV shown in Fig. S5. We attribute these observations
to membrane self-healing events, where the pores/defects
reseal and the membrane regains its permeability barrier,
followed by later phases of increased leakage. This is par-
ticularly observed for the larger 3k-CB and 10k-AF647
leakage probes. Therefore, the membrane permeability for
PC and PC/PS GUVs, in particular, can change dynamically
during the observed leakage events; this is a result of the
competition between the lipid bilayer and peptides in main-
taining their barrier properties and inducing membrane
pores, respectively (Fig. S5).
Our leakage kinetic profiles were used to calculate the
membrane permeability to the different-sized probes using
a diffusional model for membrane translocation (29); the
membrane permeability is the gradient of the log-linear
plot as seen in the example data in Fig. 6, a and c. Average
permeability values for each membrane composition to each
probe size during the initial leakage events are shown in
Table 2. It can be seen that, for all membrane compositions
tested, average permeability decreases with increasing
probe size. However, the most significant finding from this
data is the large, one-order-of-magnitude increase, in mem-
brane permeability for membrane compositions containing
10% PE. This can be observed for all three leakage markersFIGURE 6 PE lipids facilitate much greater membrane permeability in
GUV membranes. (a) Typical log-linear plot of time-dependent dye influx:
R/3ln(1c) (105) versus time, for the three dyes in a single GUV of
PC/PS. (b) Distributions of the obtained permeabilities in single GUVs
composed of PC/PS. (c) Typical log-linear plot of time-dependent dye
influx: R/3ln(1c) (105) versus time, for the three dyes in a single
GUVof PC/PE/PS. (d) Distributions of the obtained permeabilities in single
GUVs composed of PC/PE/PS. The permeabilities are obtained from the
slopes of the log-linear plots of the time-dependent influx of dyes into sin-
gle GUVs. To see this figure in color, go online.studied. It can also be seen that the presence of PS in the
membrane imparts a modest, but significant, increase in
permeability on the membranes upon perturbation by
MP1. This effect can be seen further in Fig. 6, b and d, which
show the distributions of permeability measurements for
PC/PS and PC/PE/PS GUVs to the CF and 10k-AF647
leakage markers, respectively. For both probe sizes, the ma-
jority of permeability measurements for PC/PS membranes
were in the 0–25 nm/s range, whereas when PE was
included in the membrane formulations, a large proportion
of permeability measurements were >500 nm/s.
It should be noted that the observed permeability dis-
tributions (Fig. 6, b and d) are broad due to the fact that pep-
tide-induced pores do not have well-defined structures, pore
formation events are stochastic, and the membrane inter-
faces are fluid, giving rise to this wide distribution of indi-
vidual permeability events when measured at the single
vesicle level. Indeed, it has previously been reported that
the initial pores that form during peptide-induced pore for-
mation might be far from equilibrium and can, for example,
relax to a smaller size over longer timescales as has been
observed for the peptides Bax-a5 (23) and magainin 2 (30).
The permeability data was used to calculate the effective
fractional permeable area of the membrane for each probe
size using the expression (29)
Ap
Av
¼ Pm
D0
d;
where Ap is the permeable area of membrane on a GUV, Av
is the total area of the vesicle, Pm is the permeability, and d is
the thickness of the membrane. The Stokes-Einstein diffu-
sion constant of the leakage marker is D0 ¼ kT/6phR0,
where kT is the thermal energy, h is the solvent viscosity,
and R0 is the hydrodynamic radius of the fluorescent dye
that was estimated with the relation R0 ¼ 0.0332(Mw)0.463
in nanometers (31); Mw is the molecular weight of the
dye. A brief derivation of this equation is presented in the
Supporting Material. It should be noted that this equation
is most accurate for the formation of large membrane pores
as it assumes that the diffusion constant of the dye within the
pore is the same as its diffusion constant in bulk solution.
However, we believe this to be a reasonable assumption
because these passive leakage markers will have a very short
residence time within the pore itself due to the bilayer only
being ~5-nm thick; these solutes are not expected to interact
strongly with the membrane itself.
Values of the fractional permeable areas are shown in
Table 2. The fractional permeable areas were also found
to be an order-of-magnitude greater for membrane composi-
tions containing PE than for those that did not. Note that
slightly larger permeable areas were measured for the larger
leakage markers; these represent a later time point in
the membrane disruption of GUVs by MP1 as the smaller
leakage markers translocate the membrane at earlier times
(Table 1). This extended delay time therefore allows for aBiophysical Journal 109(5) 936–947
TABLE 2 Average permeability values (hPmi) and the average fractional permeated area per vesicle (hApi/hAvi) obtained from the
average permeability values for each probe size and membrane composition
hPmiCF (nm/s) hApi/hAviCF (106) hPmi3k-CB (nm/s) hApi/hAvi3k-CB (106) hPmi10k-AF647 (nm/s) hApi/hAvi10k-AF647 (106)
PC 46 5 14 0.455 0.14 17 5 6 0.505 0.16 85 2 0.445 0.08
PC/PS 59 5 12 0.585 0.12 29 5 6 0.905 0.20 235 4 1.305 0.20
PC/PE 4665 143 4.605 1.40 2075 102 6.505 3.40 1585 53 8.805 2.90
PC/PE/PS 5895 142 5.805 1.40 3335 73 10.405 2.80 1695 52 9.405 2.90
The errors represent the standard deviation of the observed GUV data set.
944 Leite et al.greater area of membrane disruption to occur before the
initiation of leakage to the larger Mw dyes.
Besides the order-of-magnitude increase in membrane
permeabilization in the presence of PE lipids, we found an
interesting correlation between PE content and membrane
morphological response to MP1. Without PE, PC and
PC/PS GUVs exhibited bright spots of fluorescent lipids at
specific locations on the membrane surface in the presence
of 4.0 mM MP1 (Fig. 7). We attribute these observations to
local aggregation of peptides and lipids at the GUV surface.
These peptide-induced lipid aggregates may be in competi-
tion with the pore-/defect-forming activity of the peptides.
Such dense lipid structures were not seen on GUVs contain-
ing PE (PC/PE and PC/PE/PS) upon introduction of the
peptide. Therefore, we speculate that the PE suppresses
the intramembrane lipid aggregation by more easily facili-
tating the poration of the membrane.
While localized lipid aggregation was not observed on the
surface of the PE-containing GUVs, these GUVs were
observed to decrease in diameter by ~10–15% over a period
of ~1 h after peptide addition (Fig. S6). Contrary to this, PC
and PC/PS GUVs remained at a constant size for up to 2 h
after addition of MP1. Therefore, MP1 results in the signif-
icant loss of lipid from only those GUVs that contain PE
lipids.Direct imaging of peptide-induced pores by AFM
AFM imaging of supported lipid bilayers confirms the role
of PE in potentiating the formation of larger transmembrane
pores. MP1 was added at 10 mM concentration to induce sig-
nificant pore formation on the relatively small patches
of membrane imaged by the AFM within a reasonable ex-
perimental timescale (<2 h); resultant pores/defects wereBiophysical Journal 109(5) 936–947observed to be much larger in PC/PE/PS membranes
(250 5 110 nm in diameter) compared to PC/PS (54 5
30 nm in diameter) (Fig. 8). Similar-sized transmembrane
pores were observed in PC/PE/PS and PC/PE membranes
(2905 200 nm in diameter), but significantly fewer defects
formed in PC/PE membranes. Note that the large standard
deviations in these average pore diameters represent a sig-
nificant size polydispersity in the defects formed. No pores
were evident in PC membranes 2 h after peptide addition
(Fig. S7); however, pores would need to be several nanome-
ters in diameter to be observable by AFM, considerably
larger than those that can be detected by passive dye influx
into the GUVs we used to investigate the early stages of
GUV poration.
Our AFM studies also clearly show a difference in pore
formation and growth mechanisms dependent on the pres-
ence of PE. The large transmembrane pores in PC/PE/PS
and PC/PE membranes are seen to grow by the stepwise
loss of lipid aggregates from the edge of the pore, implying
that vesicle micellization is important for pore growth in the
these membranes (Fig. S8). This is consistent with the small
decrease (within experimental error) in GUV size observed
for PE-containing GUVs by phase contrast microscopy
(Fig. S6). Conversely, in PC/PS membranes, raised areas
of lipid are first seen to form on the membrane (Fig. S9),
which may correlate to the dense lipid structures observed
in Fig. 7. These raised areas of membrane later evolve
into comparatively small pores; many of the defects seen
in Fig. 8 (bottom left) only span half the bilayer, with only
the center of a few of these defects showing full bilayer
pores (Fig. S10). This indicates that pores in these mem-
branes may form via a half-membrane intermediate state.
Finally the timescale for observation of membrane defects
by AFM was much faster for PC/PE/PS membranes thanFIGURE 7 Lipid aggregation is observed within
the membranes of GUVs lacking in PE. Images of
local lipid aggregation at the GUV surface (bright
localized spots of fluorescence) seen after peptide
addition (Cp ¼ 4.0 mM). This effect is frequently
observed in PC and PC/PS GUVs, but not for the
lipid mixtures containing 10 mol % PE. To see
this figure in color, go online.
FIGURE 8 AFM images provide direct evidence that larger pores form in
PE-containing membranes. AFM images of the four different membrane
compositions 2 h after the addition of 10 mMMP1. Large pores can clearly
be seen in PC/PE/PS and PC/PE membranes with a larger number of pores
in the former. PC/PS shows much smaller defects, while no membrane
perturbation is resolvable by AFM for PC membranes. To see this figure
in color, go online.
Membrane Poration by Anticancer Peptide 945for other lipid mixtures, with defects observed almost
immediately after peptide addition (Fig S7), compared
with a few tens of minutes for other mixtures.DISCUSSION
Biophysical implications for MP1-lipid membrane
interactions
We have shown a synergistic enhancement of the rate and
extent of membrane permeabilization by MP1 peptides
when PE and PS lipids are present in the lipid membrane.
This picture is confirmed and corroborated by complemen-
tary experiments using three different model membrane
systems: LUVs, GUVs, and planar-supported bilayers. We
consider the perturbation of the membrane by MP1 peptides
in two steps: 1) binding of the peptides to the membrane,
and 2) perturbation of the bilayer structure by bound pep-
tides to induce leakage.
Binding isotherms (Fig. 2) reveal that PS lipids cause a
7–8-fold increase in peptide bound to the membrane. This
strongly outweighs the small ~10% reduction in bound
peptide concentration caused by the PE lipids. Therefore,
we find that the dominant role of PS lipids’ contribution
to the membrane disruption by MP1 is a large increase in
peptide binding to the membrane.
The role of PE lipids in MP1-induced membrane disrup-
tion is twofold: 1) PE increases the susceptibility of the
membrane to permeabilization by bound peptides, and 2)
PE facilitates the formation of larger transmembrane pores.
First, when the extent of GUV leakage is normalized tobound peptide concentration in the dose-response curves
in Fig. 3, c and d, it can be seen that 4–5 times lower bound
peptide concentration is required to induce a similar leakage
response compared to comparable GUVs without PE lipids.
Second, GUV and AFM experiments corroborate the effect
of larger pores forming in the presence of PE. Quantitative
analysis of GUV leakage profiles in Fig. 6 and Table 2 reveal
that the presence of PE increases the permeability of mem-
branes by an order of magnitude compared to membranes
lacking in PE. Furthermore, once pores formed in GUVs,
they quickly (within seconds) grew large enough in size to
allow larger macromolecules (3 and 10 kDa) to permeate
the membrane (Table 1); this compared to several tens of
seconds for larger pores to form in GUVs lacking PE.
Crucially, the formation of larger pores for PE-containing
membranes is directly visualized by AFM (Fig. 8), where
the observed pore diameters are ~5 times larger in the pres-
ence of PE (and hence ~20–30 times larger in average pore
area, consistent with the order-of-magnitude increase in
permeability reported for the GUVs).
The formation of transmembrane pores was confirmed
by complementary experimental systems and techniques.
Rapid translocation of membrane-impermeable leakage
markers across GUV membranes, an all-or-none LUV fluo-
rescence leakage assay, and direct visualization of trans-
membrane defects by AFM imaging of planar bilayers, all
confirm this to be true. While these pores are fairly long
lived, the membranes were sometimes observed to tempo-
rarily reseal, regaining their barrier properties. This can
clearly be seen in the leakage profiles of individual GUVs
in Figs. 5 a, S4, and S5. GUV and planar bilayer imaging
experiments also strongly suggest differences in the mech-
anism of pore formation depending on whether PE lipids
are present. Images of GUVs that did not contain PE lipids
often exhibited bright spots of increased local lipid con-
centrations on the membrane, which we interpret to be
local aggregation of peptides and lipid (Fig. 7). Similarly,
AFM images showed locally raised regions of lipid scat-
tered across the membrane for these lipid compositions
(Fig. S9) before the formation of pores (Fig. S10). This con-
trasted to the pore-formation mechanism observed in the
presence of PE, where local aggregates were not directly
observed on the GUV surface and time-resolved AFM
imaging showed pore growth to occur by the stepwise mi-
cellization and loss of lipid from the edge of the pores
(Fig. S8).
Besides the increased binding due to PS and the increased
membrane susceptibility and pore size due to PE, the syner-
gistic enhancement of membrane disruption facilitated by
these lipids can be observed in the kinetics of initial perme-
abilization events. GUVexperiments showed that PC/PE/PS
GUVs leaked a factor-of-two quicker than other membrane
compositions (Table 1). This is again corroborated by
the AFM studies where defects were observed in PC/PE/
PS membranes almost immediately after peptide addition,Biophysical Journal 109(5) 936–947
946 Leite et al.whereas perturbations of other membrane compositions
took a few 10 s of minutes to evolve. The complementary
pore-promoting effects of PS on bound peptide concentra-
tions and PE on membrane susceptibility far outweigh
their slight inhibitory effects on each other’s roles (PE
causes a slight reduction in binding affinity (Fig. 2) and
PS causes a decrease in the membrane susceptibility to
bound peptide (Fig. 3, c and d)). This is apparent from the
effects of MP1 on GUVs, where PC/PE/PS membranes
experience the greatest membrane perturbation for any
given total peptide concentration (Fig. 3, a and b) and the
larger number of pores observed on the membrane surface
by AFM (Fig. 8). Therefore, our combined results provide
a detailed mechanistic picture of the importance of
increased PS and PE lipid concentrations in synergistically
enhancing the membrane’s propensity for significant disrup-
tion of its barrier properties by MP1 peptides.
Variations in lipid composition are responsible for differ-
ences in membrane properties such as charge, fluidity,
lateral pressure profiles, and mechanical moduli. Changes
in these fundamental membrane properties directly affect
their interactions with extraneous compounds, such as anti-
microbial peptides. The cationic nature of the MP1 peptide
is likely an important component in the initial step
of peptide action, in which the peptide recognizes the target
membrane due to electrostatic interactions and binds to it
in a structured form, most of the time as a helix. Therefore,
the inclusion of anionic PS lipids in these membranes in-
creases these electrostatic interactions with the MP1 peptide
(net charge ¼ þ2e). However, MP1-membrane interactions
cannot be solely driven by electrostatics as these peptides
were also found to disrupt zwitterionic PC and PC/PE
membranes, likely through secondary hydrophobic initial
binding interactions that lead to a significantly lower
bound concentration of peptide compared to the anionic
membranes.
Next, insertion of the peptide into the bilayer likely takes
place due to the hydrophobic effect, where nonpolar MP1
residues insert into the bilayer core, and defects may then
be opened within the membrane structure, leading to its
disruption. Furthermore, taking account of the fact that
MP1 is a short peptide (14 amino acids) and hence not
long enough to form a bilayer-spanning barrel stave pore
(9,32), we anticipate that these pores will be disorganized
toroidal structures formed by lipids and peptides, as
described by many molecular-dynamics studies (33,34).
PE is known to significantly modulate the lateral pressure
profile through membranes and thereby induce negative cur-
vature stress in the bilayer. Negative curvature stress has
been shown to enhance the formation of toroidal lipid pores
within a membrane by stabilizing the curvature of these
structures (35). Therefore, PE would be expected to favor
the formation of pore-like defects in the membrane, consis-
tent with the increase susceptibility of these membranes to
MP1-induced poration and the order-of-magnitude increaseBiophysical Journal 109(5) 936–947in membrane permeability that we find for PE-containing
membranes upon interaction with MP1 peptides.Implications for the chemotherapeutic potential
of MP1 peptides
The MP1 peptide has been shown to have selective inhibi-
tion against numerous cancer lines compared to healthy
cells (2,3). Such malignant cells are also known to have
increased expression of PS and PE lipids on their outer
plasma membrane (5–7). This study strongly correlates
the enhanced tumor inhibitory effects of these peptides
with this pathological change in plasma membrane lipid
composition, where the upregulation of PS and PE lipids
can synergistically enhance the membrane-permeabilizing
activity of MP1. This membrane permeabilization is likely
to be the primary mechanism of cancer cell death induced
by these peptides.
This suggests that MP1 might be a candidate therapeutic
for development of novel cancer therapies, or at least guide
the development of novel lead compounds for treatment of
these diseases. One challenge for the application of antimi-
crobial peptides in medicine is that they often do not show
high enough selectivity to their target cells to result in a
favorable therapeutic index for these compounds (36). How-
ever, MP1 does not exhibit hemolytic activity to rat erythro-
cytes but presents chemotaxis for polymorphonucleated
leukocytes and potent antimicrobial action against Gram-
positive and Gram-negative bacteria (12), suggesting it
could have favorable selectivity. It may also be of interest
to test MP1 in a combination therapy with other chemother-
apeutics that have intracellular targets. The selectivity of the
MP1 peptide to disrupt the membranes of cancer cells may
act synergistically with these other drugs to significantly
enhance the therapeutic potency. Therefore, the therapeutic
potential of this and other membrane-active peptides within
the field of oncology is worthy of further investigation.SUPPORTING MATERIAL
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Brief derivation of the relationship between membrane permeability and fractional 
permeable area of membrane. 
This follows the arguments previously presented by Philip Nelson (Nelson P. 2004. Biological 
Physics: Energy, Information, Life (Freeman, New York)). 
We consider a cylindrical water channel across of biological membrane of length δ, where δ is the 
bilayer thickness. Initially the concentration of solute (c) outside of the vesicle is c0 and inside the 
vesicle is 0. Solute will diffuse through the pore to equilibrate the concentration gradient, ∆𝑐, across 
the membrane. After a brief initial phase of solute influx, a quasi steady state is reached where 
𝑑𝑐 𝑑𝑡⁄ = 0. Given the diffusion equation, 
𝑑𝑐
𝑑𝑡
= 𝐷0 𝑑2𝑐𝑑𝑥2 
where D0 is the diffusion constant of the solute. This implies that 𝑑2𝑐 𝑑𝑥2⁄ = 0, where x is the 
spatial coordinate along the length of the pore, parallel to the bilayer normal. This can be solved 
with the boundary conditions 𝑐(0) = 𝑐0 and 𝑐(𝛿) = 0 to give 𝑐 = 𝑐0(1 − 𝑥 𝛿⁄ ). By Fick’s law, it 
then follows that the flux 𝑗 = −𝐷0 ∆𝑐 𝛿⁄ , which can be written as 𝑗 = −𝑃𝑝∆𝑐, where 𝑃𝑝 = 𝐷0 𝛿⁄  is 
the permeability of a single pore. 
If we consider a larger membrane area that might have multiple pores, the diffusive transport across 
the membrane will only occur through the fraction of the total membrane area (α) that is porous. 
Therefore the permeability of the membrane, 𝑃𝑚 = 𝛼𝐷0 𝛿⁄ , which can be rearranged to give 
𝐴𝑝
𝐴𝑣
= 𝑃𝑚
𝐷0
𝛿 
Where Ap is the total area of pores on a vesicle of area Av. 
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Figure S1. GUV leakage data plotted as average % dye leakage across the GUV population against 
(a, b) total peptide concentration, and (c, d) peptide concentration bound to the membranes for the 
different membrane compositions studied. (a, c) leakage of the CF probe; (b, d) leakage of the 10k-
AF647 probe. The error bars were obtained through the mean standard deviation of the observed 
GUVs set. 
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Figure S2 – GUV leakage histograms. Fractional leakage histograms for 50 GUVs per lipid 
composition after 30 min. incubation with (1) 1.2 µM and (2) 4.0 µM of MP1. Individual GUVs are 
ordered left to right from lowest to highest leakage %. Lipid compositions are (A) PC, (B) PC/PS, 
(C) PC/PE and (D) PC/PE/PS. Leakage is analysed for the CF (green) and 10k-AF647 (magenta) 
probes. Horizontal lines at 20% and 80% leakage represent the thresholds used to categorized 
leaked vesicles and fully leaked vesicles, respectively. Note that partially leaked vesicles are 
comparatively rare for these peptide – membrane systems.  
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Figure S3 - Phase Contrast of GUVs. Peptide solution was added to GUVs solution to reach a 
final concentration of 10 µM. Before the peptide addition, at t=0, GUVs were observed in the 
sample. After the peptide addition, the GUVs are observed to have been completed disrupted 
(lysed) after 30 min. a- GUVs composed of PC are shown in t=0, and 30 min after peptide addition 
in the same region of the sample; almost no more GUVs are observed. b- GUVs composed of 
PC/PE/PS are shown in t=0, and 30 min after peptide addition at the same region; almost no more 
GUVs are observed. 
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Figure S4. Example profiles for the typical kinetics of single vesicle permeation due to the addition 
of MP1 at 4.0µM final concentration in four lipid compositions: by PC, PC/PS, PC/PE and 
PC/PE/PS.  
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Figure S5. A permeability plot for a PC/PS GUV that clearly exhibits significant changes in 
membrane permeability during the initial leakage events. The permeability to the CF probe changes 
dynamically from 1 nm/s to 340 nm/s to 64 nm/s with abrupt transitions between these stages.  
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Figure S6 - Phase contrast images of GUVs composed of (a) PC/PE/PS and (b) PC/PS are obtained 
for a period of 2 h. after addition of 4.0 μM MP1. a- At t=30min most of the phase contrast of the 
GUV is lost, due to leakage of the encapsulated sucrose solution; the vesicle structure integrity is 
kept intact for ~1 h. after the contrast is lost. The vesicle size decreased with increasing time of 
peptide interaction according to: at t ≈ 0 the vesicle diameter (d) was 19 ± 1 µm; at t ≈ 30 min., d= 
18 ± 1 µm; at t ≈ 60 min., d = 17 ± 2 µm; and at t ≈ 85 min. the vesicle had lost its integrity. b- At t 
= 30 min. most of the phase contrast is lost from the GUV and the vesicle structure integrity 
remains intact over 2 h. after the contrast decreasing. The vesicle size does not changed with 
increasing time of peptide interaction; the vesicle diameter remained at 25 µm during the 
observation time. 
  
9 
 
 
 
 
Figure S7. AFM images of a DOPC membrane 80 min. after addition of 10 μM MP1. No clear 
defects can be observed, but a textured bilayer surface can be seen if the z-contrast is enhanced by a 
factor of 10. This could indicate a layer of absorbed peptide. 
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Figure S8. AFM image showing 10-20 nm pin-holes (black arrows) in PC/PE/PS membranes in the 
first scan, 5 min. after addition of 10 μM MP1. In addition feint “blisters” (some depicted by red 
arrows) can be seen, which will later develop into pores. A larger pore can be seen top centre-left 
with a vesicle forming at the edge; vesicle micellisation at the pore rim was observed in time lapse 
sequences to be the quantized growth mechanism of larger pore defects. 
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Figure S9. AFM images of PC/PS membranes. (Left) 5-10 min. after addition of 10 μM MP1 
“blisters” can be observed in the membrane that will eventually form pores. (Right) Pores observed 
in the membrane at 2 h after peptide addition. Interestingly, note that the blisters and pores appear 
to form along a network of lines on the membrane, implying that there may be some cooperativity 
between the occurrences of neighboring membrane defects. 
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Figure S10. AFM image showing the structural details of pores in PC/PS membranes. Half-bilayer 
defects (mid-brown) can be observed, along with pores containing full-bilayer pores in their centre 
(black). 
 
 
 
